Preferred valorisation partner of MELiSSA pharmaceutical IP
ezCOL BV was established in the ESA Business Incubator in Noordwijk, The Netherlands.
Highly focused on the safety of new drug candidates
It is our mission to provide the best therapeutics to patients around the world by tapping into research activities aimed for long term humna space missions. The MELiSSA consortium focusses on life support systems in its broadest sense to enable long space flights. The mulitnational research and development activities in MELiSSA are spanning over 100 researchers at 60 different research institutes and organizations. ezCOL fosuses on the development of new drugs based on intellectual property derived from the MELiSSA consortium that has beneficial effects on human health and novel disease treatment options.
Our vision is to develop state-of-the-art drugs that benefit the human race. We aim to provide society future-proof therapeutics with lowest adversity and at affordable costs. This way we bring health benefits to people and keep our health care systems viable.